ADIM
ACA icon

Alpha DNA Investment Management’s Arcosa ACA Stock Holding History

Alpha DNA Investment Management’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-35
Closed -$1K – 675
2020
Q4 		$1K Buy
+35
New +$1.79K ﹤0.01% 504

Other funds holding ACA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alpha DNA Investment Management's ACA Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Arcosa (ACA) in Q1 2021, closing a stake of 35 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in ACA in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 265 funds tracked by Wall St. Rank hold ACA as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Arcosa position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 35 Arcosa shares in Q1 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Arcosa in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Arcosa position peaked at $1K in Q4 2020.
  • 265 funds tracked by Wall St. Rank held Arcosa as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.